Evolvere BioSciences

Oxford, United Kingdom

Evolvere BioSciences develops next-generation antibiotics using AI-driven co-evolutionary models to outpace bacterial resistance.

$500K raised

Sep 2024

Pre-Seed

Artificial Intelligence (AI)Bioinformatics Biotechnology

Top Investors

Y Combinator

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Evolvere BioSciences

How much funding has Evolvere BioSciences raised?

Evolvere BioSciences has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2024.

Who are Evolvere BioSciences's investors?

Evolvere BioSciences's investors include Y Combinator.

Where is Evolvere BioSciences headquartered?

Evolvere BioSciences is headquartered in Oxford, United Kingdom.

What does Evolvere BioSciences do?

Evolvere BioSciences develops next-generation antibiotics using AI-driven co-evolutionary models to outpace bacterial resistance.

What stage is Evolvere BioSciences at?

Evolvere BioSciences is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 25, 2024.

MLA

"Evolvere BioSciences — Funding & Investors." VCBacked, September 25, 2024, https://www.vcbacked.co/company/evolvere-biosciences. Accessed June 17, 2026.

APA

VCBacked. (2024). Evolvere BioSciences — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/evolvere-biosciences

Wikipedia (cite web)

{{cite web |title=Evolvere BioSciences — Funding & Investors |url=https://www.vcbacked.co/company/evolvere-biosciences |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 25, 2024.